Ledger.Open graph →
SEC Form D · Amendment · filed January 30, 2014

SYMIC BIOMEDICAL, INC

Offering
$1.5M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Kenneth N. Horne · SAN FRANCISCO, CAExec · DirectorKate N. Stuart · SAN FRANCISCO, CAExecAlyssa N. Panitch · SAN FRANCISCO, CADirectorJohn N. Paderi · SAN FRANCISCO, CADirectorRichard A. Magnuson · MENLO PARK, CAExec · DirectorAmru A. Khan · Los Angeles, CAExecTerrence Wall · Madison, WIDirectorCharlie R. Martin · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗